MPS II (Hunter Syndrome) Disease Activity Assessment

Assesses Hunter syndrome (MPS II) disease activity through uGAG levels, neurocognitive function, 6-minute walk test, joint range of motion, and cardiac valve status for enzyme replacement therapy monitoring.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Assesses Hunter syndrome (MPS II) disease activity through uGAG levels, neurocognitive function, 6-minute walk test, joint range of motion, and cardiac valve status for enzyme replacement therapy monitoring. Use the mps ii assessment result to inform your calculation.

Frequently Asked Questions